Avecho Biotechnology Ltd News

Avecho Biotechnology Ltd: Receipt of R&D Tax Incentive

Jun 13 07:26

Avecho Biotechnology Ltd: First Patient dosed in Phase III insomnia trial

May 16 07:09

Avecho Biotechnology Ltd: March 2024 Quarterly Activities Report & Appendix 4C

Apr 30 07:53

Avecho Biotechnology Ltd: Initial Director's Interest Notice

Apr 26 09:49

Avecho Biotechnology Ltd: Monash Sleep Health Symposium

Apr 22 07:23

Avecho Biotechnology Ltd: Avecho commences Phase III insomnia trial

Mar 26 05:31

Avecho Biotechnology Ltd: Avecho to present at NWR Virtual Healthcare Conference

Mar 18 06:24

Avecho Biotechnology Ltd: Avecho meets TGA ahead of Phase III Clinical Trial

Mar 14 07:25

Avecho Biotechnology Ltd: AVE receives final ethics approval for Phase III CBD trial

Mar 7 06:31

Avecho Biotechnology Ltd: Appendix 4G and Corporate Governance Statement

Feb 29 14:42

Avecho Biotechnology Ltd: December 2023 Quarterly Activities Report & Appendix 4C

Jan 31 05:50

Avecho Biotechnology Ltd: Expiry of Quoted Options

Nov 28, 2023 06:41

Avecho Biotechnology Ltd: Change of Director's Interest Notice x2

Nov 23, 2023 10:27

Avecho Biotechnology Ltd: September 2023 Quarterly Activities Report & Appendix 4C

Oct 31, 2023 06:08

Avecho Biotechnology Ltd: Phase III Clinical Trial Investor Webinar

Oct 11, 2023 07:03

Avecho Biotechnology Ltd: Reinstatement to Official Quotation

Aug 28, 2023 08:40

Avecho Biotechnology Ltd: Voluntary Suspension

Aug 25, 2023 06:55

Avecho Biotechnology Ltd: Trading Halt

Aug 23, 2023 07:40

Avecho Biotechnology Ltd: June 2023 Quarterly Activities Report & Appendix 4C

Jul 25, 2023 06:59

Avecho Biotechnology Ltd: AVE CBD capsule passes two-year stability milestone

Jun 22, 2023 06:57